The calcium channel blocker controversy

Hypertension Research - Clinical and Experimental

Volumn 19, Issue 2, 1996, Pages 57-64

  Kaplan, Norman M ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Calcium channel blockers; Coronary disease; Hypertension

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE; NIFEDIPINE; NISOLDIPINE;

ACUTE HEART INFARCTION; BLEEDING; CARDIOTOXICITY; DRUG EFFICACY; DRUG SAFETY; HEART ARRHYTHMIA; HYPERTENSION; HYPOTENSION; MORTALITY; REVIEW;

EID: 0030055925     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.19.57     Document Type: Review

References (34)

1. Fleckenstein A: History of calcium antagonists. Circ Res 1983; 52: 3-16.
2. Lüscher TF, Wenzel RR, Moreau P, Takase H: Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases. Cardiovasc Drugs Ther 1995; 9: 509-523.
3. Kaasjager KAH, Rijn HJMV, Koomans HA, Rabelink TJ: Interactions of nifedipine with the renovascular effects of endothelin in humans. J Pharmacol Exp Ther 1995; 275: 306-311.
4. Ting CT, Chen JW, Chang MS, Yin FCP: Arterial hemodynamics in human hypertension: effects of the calcium channel antagonist nifedipine. Hypertension 1995; 25: 1326-1332.
5. Materson BJ, Reda DJ, Cushman WC: Department of veterans affairs single-drug therapy of hypertension study. Am J Hypertens 1995; 8: 189-192.
6. Neaton JD, Grimm RH, Prineas RJ, et al: Treatment of mild hypertension study: final results. JAMA 1993; 270: 713.
7. Kaplan NM: Treatment of hypertension: drug therapy. In Kaplan NM (ed): Clinical Hypertension, 6th Edition. Baltimore: Williams & Wilkins 1994; 191-280.
8. Skoularigis J, Strugo V, Veinberg J, et al: Effects of amlodipine on 24-hour ambulatory blood pressure profiles, electrocardiographic monitoring, and left ventricular mass and function in black patients with very severe hypertension. J Clin Pharmacol 1995; 35: 1052-1059.
9. Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Cléroux J, Boileau G: Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension. Am J Hypertens 1995; 8: 1154-1159.
10. Nazzaro P, Manzari M, Merlo M, et al: Anti-hypertensive treatment with verapamil and amlodipine: their effect on the functional autonomic and cardiovascular stress responses. Eur Heart J 1995; 16: 1277-1284.
11. Dohi Y, Kojima M, Sato K: Effect of intravenous calcium antagonists on left ventricular diastolic function in hypertension: assessed by pulsed-Doppler echocardiogram. J Hypertens 1995; 13: 543-549.
12. Messerli FH, Nunez BD, Nunez MM: Hypertension and sudden death: disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 1989; 149: 1263.
13. Henry PD, Bentley KI: Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest 1981; 68: 1366-1369.
14. Yang Z, Noll G, Lüscher TF: Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. Circulation 1993; 88: 832-836.
15. Loaldi A, Polese A, Montorsi P, et al: Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol 1989; 64: 433-439.
16. Waters D, Lespérance J, Francetich M, et al: Progression of coronary atherosclerosis. Circulation 1990; 82: 1940-1953.
17. Lichtlen PR, Hugenholtz PG, Rafflenbeul W: Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990; 335: 1109-1113.
18. Hansson L, Zanchetti A: The antiatherosclerotic effect of calcium antagonists in man: what did Midas actually show. Blood Pressure 1995; 4: 133-136.
19. Polónia J, Boaventura I, Gama G, et al: Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens 1995; 13: 25-31.
20. Luft FC, Fineberg NS, Weinberger MH: Long-term effect of nifedipine and hydrochlorothiazide on blood pressure and sodium homeostasis varying levels of salt intake in mildly hypertensive patients. Am J Hypertens 1991; 4: 752-760.
21. Burris JF, Weir MR, Oparil S, et al: An assessment of diltiazem and hydrochlorothiazide in hypertension. JAMA 1990; 263: 1507-1512.
22. Griffin KA, Picken MM, Bidani AK: Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 1995; 96: 793-800.
23. Velussi M, Brocco E, Frigate F, et al: Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996; 45: 216-222.
24. Fioretto P, Frigato F, Velussi M, et al: Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. AJH 1992; 5: 837-846.
25. Bakris GL, Williams B: Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ. J Hypertens 1995; 13(Suppl 2): S95-S101.
26. Rich S, Kaufmann E, Levy PS: The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
27. Scognaminglio R, Rahimtoola SH, Fasoli G, et al: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994; 331: 689-694.
28. Fisher M, Grotta J: New uses for calcium channel blockers. Therapeutic implications. Drugs 1993; 46: 961-975.
29. Fenakel K, Lurie S: The use of calcium channel blockers in obstetrics and gynecology: a review. Eur J Obstet Gynecol Reprod Biol 1990; 37: 199-203.
30. Boissel JP, Collet JP, Lion L, et al: A randomized comparison of the effect of four antihypertensive monotherapies on the subjective quality of life in previously untreated asymptomatic patients: field trial in general practice. J Hypertens 1995; 13: 1059-1067.
31. Held PH, Yusuf S, Furbert CD: Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989; 229: 1187-1192.
32. Muller J, Morrison J, Stone PH, et al: Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation 1984; 69: 740-747.
33. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.
34. Lichtlen PR: Risks and benefits of calcium antagonist. Lancet 1995; 346: 961.